Journal article
DIFFERENTIAL IMMUNOGENICITY OF VACCINIA AND HIV-1 COMPONENTS OF A HUMAN RECOMBINANT VACCINE IN MUCOSAL AND BLOOD COMPARTMENTS
Vaccine, Vol.26(35), pp.4617-4623
08/18/2008
Handle:
https://hdl.handle.net/2376/116573
PMCID: PMC2570228
PMID: 18621451
Abstract
Mucosal immune responses induced by HIV-1 vaccines are likely critical for prevention. We report a Phase 1 safety and immunogenicity trial in 8 participants using the
vaccinia
-based TBC-3B vaccine given subcutaneously to determine the relationship between HIV-1 specific systemic and gastrointestinal mucosal responses. Across all subjects, detectable levels of blood
vaccinia
- and HIV-1-specific antibodies were elicited but none were seen mucosally. While the
vaccinia
component was immunogenic for CD8
+
T lymphocyte (CTL) responses in both blood and mucosa, it was greater in blood. The HIV-1 component of the vaccine was poorly immunogenic in both blood and mucosa. Although only 8 volunteers were studied intensively, the discordance between mucosal and blood responses may highlight mechanisms contributing to recent vaccine failures.
Metrics
17 Record Views
Details
- Title
- DIFFERENTIAL IMMUNOGENICITY OF VACCINIA AND HIV-1 COMPONENTS OF A HUMAN RECOMBINANT VACCINE IN MUCOSAL AND BLOOD COMPARTMENTS
- Creators
- Peter A Anton - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLAF Javier Ibarrondo - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLAW. John Boscardin - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLAYing Zhou - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLAElissa J Schwartz - Department of Mathematics and School of Biological Sciences, Washington State University, Pullman, WAHwee L Ng - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLAMary Ann Hausner - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLARoger Shih - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLAJulie Elliott - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLAPatricia M Hultin - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLALance E Hultin - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLACharles Price - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLAMarie Fuerst - Tower Cancer Research Foundation, Beverly Hills, CAAmy Adler - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLAJohnson T Wong - Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MassachusettsOtto O Yang - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLABeth D Jamieson - UCLA AIDS Institute and Department of Medicine, Immunology and Molecular Genetics, David Geffen School of Medicine at UCLA
- Publication Details
- Vaccine, Vol.26(35), pp.4617-4623
- Academic Unit
- Biological Sciences, School of
- Identifiers
- 99900547993001842
- Language
- English
- Resource Type
- Journal article